Table 1 Demographic and bleeding data for patients receiving 5 % human albumin (HA) or hydroxyethyl starch 130/0.4 (HES) during elective neurosurgery up to the end of surgery (eos)
HES (n = 18) | HA (n = 21) | |
|---|---|---|
Gender (male/female) | 10/8 | 7/14 |
Median age (min-max) | 51(21–86) | 54(20–73) |
Blood loss (n) | 100–499 ml (7) | 100–499 ml (8) |
500–999 ml (4) | 500–999 ml (3) | |
1000–1999 ml (5) | 1000–1999 ml (4) | |
≥2000 ml (1) | ≥2000 ml (0) | |
Total colloid volume received (n) | 500 ml (5) | 250 ml (10) |
1000 ml (13) | 500 ml (11) | |
Total NaCl volume received (n) | 2000 ml (15) | 2000 ml (16) |
2500 ml (2) | 2500 ml (5) | |
3000 ml (2) | ||
Median preoperative Hb (min-max) | 128 g/L (99–148) | 127 (97–144) |
Median eos Hb (min-max) | 116 g/L (96–122) | 113 g/L (94–144) |